Thorne Healthtech, Inc. Common Stock
THRN
THRN was delisted on the 13th of October, 2023.
44 hedge funds and large institutions have $17.3M invested in Thorne Healthtech, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 6 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0% more funds holding
Funds holding: 44 → 44 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
1.62% less ownership
Funds ownership: 10.51% → 8.89% (-1.6%)
34% less capital invested
Capital invested by funds: $26.2M → $17.3M (-$8.95M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1M |
| 2 |
MA
MYDA Advisors
Woodmere,
New York
|
+$665K |
| 3 |
BlackRock
New York
|
+$217K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$191K |
| 5 |
Millennium Management
New York
|
+$133K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$4.83M |
| 2 |
SI
Scout Investments
Kansas City,
Missouri
|
-$899K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$458K |
| 4 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$76K |
| 5 |
Morgan Stanley
New York
|
-$50.8K |
THRN Hedge Fund Activity: Q4 2022 in Review
44 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q4 2022, worth a combined $17.3M — down 34% from $26.2M a quarter earlier.
Fund positioning in THRN was balanced in Q4 2022: 6 funds opened new positions, 6 closed out, 15 added to existing stakes and 14 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $4.83M sold.
- 44 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $17.3M of Thorne Healthtech, Inc. Common Stock stock for Q4 2022, down 34% quarter-over-quarter.
- 6 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q4 2022 and 6 closed out, a net change of 0 holders.
- The largest Thorne Healthtech, Inc. Common Stock buyer in Q4 2022 was Vanguard Group, an estimated $1M added.
- The largest Thorne Healthtech, Inc. Common Stock seller in Q4 2022 was Driehaus Capital Management, an estimated $4.83M sold.
Based on aggregated 13F filings for Q4 2022.